The proposed regulatory pathway for ‘emergency use’ authorization of new drugs
Last month, the Ministry of Health invited comments on a proposed amendment to the New Drugs and Clinical Trial Rules, 2019 in order to create a new regulatory pathway for patients in private hospitals to access unapproved experimental drugs under a new compassionate use policy. The existing rules already provide for such a pathway to …
The proposed regulatory pathway for ‘emergency use’ authorization of new drugs Read More »